We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-10.83%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.55B
AUM Growth
-$222M
Cap. Flow
-$13.5M
Cap. Flow %
-0.87%
Top 10 Hldgs %
17.52%
Holding
929
New
38
Increased
323
Reduced
374
Closed
111

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.49M
2
KO icon
Coca-Cola
KO
+$4.72M
3
ESRX
Express Scripts Holding Company
ESRX
+$2.71M
4
PX
Praxair Inc
PX
+$2.45M
5
XOM icon
ExxonMobil
XOM
+$2.14M

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Financials 11.52%
3 Technology 11.46%
4 Consumer Staples 8.85%
5 Industrials 7.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TLT icon
601
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
$267K 0.02%
+2,199
New +$255K
GEO icon
602
The GEO Group
GEO
$4B
$264K 0.02%
13,415
+63
+0.5% +$1.43K
JHML icon
603
John Hancock Multifactor Large Cap ETF
JHML
$1.15B
$263K 0.02%
8,194
ATR icon
604
AptarGroup
ATR
$8.69B
$262K 0.02%
2,778
-212
-7% -$21.6K
GOVT icon
605
iShares US Treasury Bond ETF
GOVT
$43.7B
$262K 0.02%
10,628
-2,401
-18% -$58.4K
GLQ
606
Clough Global Equity Fund
GLQ
$151M
$261K 0.02%
24,090
-630
-3% -$8.09K
EGIF
607
DELISTED
Eagle Growth and Income Opportunities Fund
EGIF
$261K 0.02%
20,651
+6,506
+46% +$92.5K
EQNR icon
608
Equinor
EQNR
$97.3B
$260K 0.02%
12,304
-9,614
-44% -$236K
FSD
609
DELISTED
FIRST TRUST HIGH INCOME LONG/SHORT FUND
FSD
$260K 0.02%
19,541
-718
-4% -$9.99K
ALXN
610
DELISTED
Alexion Pharmaceuticals
ALXN
$259K 0.02%
2,654
-29
-1% -$3.43K
DLN icon
611
WisdomTree US LargeCap Dividend Fund
DLN
$6.21B
$258K 0.02%
6,118
-196
-3% -$8.88K
JBHT icon
612
JB Hunt Transport Services
JBHT
$25.9B
$257K 0.02%
2,754
-414
-13% -$43.9K
MASI
613
DELISTED
Masimo
MASI
$257K 0.02%
2,394
+9
+0.4% +$1K
SPLK
614
DELISTED
Splunk Inc
SPLK
$256K 0.02%
2,449
-82
-3% -$8.29K
ABB
615
DELISTED
ABB Ltd
ABB
$256K 0.02%
13,466
-6,280
-32% -$127K
CBRL icon
616
Cracker Barrel
CBRL
$1.26B
$255K 0.02%
1,598
-25
-2% -$4.11K
HUM icon
617
Humana
HUM
$43.9B
$255K 0.02%
889
-65
-7% -$20.6K
KRE icon
618
State Street SPDR S&P Regional Banking ETF
KRE
$4.51B
$255K 0.02%
5,456
-1,201
-18% -$64.2K
SPR
619
DELISTED
Spirit AeroSystems
SPR
$255K 0.02%
3,537
+44
+1% +$3.57K
VMW
620
DELISTED
VMware, Inc
VMW
$255K 0.02%
1,856
-45
-2% -$6.8K
FTSL icon
621
First Trust Senior Loan Fund ETF
FTSL
$2.32B
$254K 0.02%
5,572
-2,143
-28% -$101K
GDX icon
622
VanEck Gold Miners ETF
GDX
$22.5B
$254K 0.02%
12,026
-927
-7% -$18.2K
NWL icon
623
Newell Brands
NWL
$2.21B
$254K 0.02%
13,674
-531
-4% -$10.6K
POST icon
624
Post Holdings
POST
$4.42B
$254K 0.02%
4,347
-72
-2% -$4.34K
TPH
625
DELISTED
Tri Pointe Homes
TPH
$254K 0.02%
23,266

Similar funds

Raymond James Trust's Q4 2018 Portfolio in Review

As of Q4 2018, Raymond James Trust held 929 positions worth $1.55B, down 12% from $1.78B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q4 2018 filing shows 38 new, 323 increased, 374 reduced and 111 closed positions. Its largest new stake was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M. The largest sale was Merck, an estimated $5.49M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Financials and Technology.

  • Raymond James Trust's largest Q4 2018 buy was iShares MSCI ACWI ETF: 66,263 shares worth $4.25M.
  • Raymond James Trust added most to Vanguard FTSE Developed Markets ETF in Q4 2018, an estimated $3.75M increase.
  • Raymond James Trust's biggest Q4 2018 reduction was Merck, cutting an estimated $5.49M.
  • Raymond James Trust fully exited Express Scripts Holding Company in Q4 2018, selling an estimated $2.71M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.55B portfolio in Q4 2018.
  • Raymond James Trust opened 38 new positions and closed 111 in Q4 2018.
  • Raymond James Trust's portfolio value fell 12% quarter-over-quarter to $1.55B.

Based on Raymond James Trust's 13F filing for Q4 2018, filed 29 Jan 2019.